Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CHR NASDAQ:INOV OTCMKTS:LPHM OTCMKTS:PBSV On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHRCheer$1.16+1.8%$1.48$1.00▼$3.45$13.85M1.0779,062 shs48,287 shsINOVInovalon$32.88-0.2%$40.92$17.56▼$41.06$5.10B0.53720,587 shs752 shsLPHMLee Pharmaceuticals$0.00$0.01▼$0.40$3.48M669.9154,707 shs18.63 million shsPBSVPharma-Bio Serv$0.60$0.59$0.31▼$0.67$13.76M0.641,268 shs2,403 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHRCheer0.00%-3.33%-36.96%-16.61%-51.18%INOVInovalon0.00%-0.53%+2.80%+3.10%+12.10%LPHMLee Pharmaceuticals0.00%0.00%0.00%0.00%-88.24%PBSVPharma-Bio Serv0.00%0.00%0.00%+20.00%-1.80%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCHRCheer1.0772 of 5 stars0.03.00.00.03.31.70.6INOVInovalon1.6562 of 5 stars0.00.00.04.30.01.72.5LPHMLee PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/APBSVPharma-Bio ServN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCHRCheer 0.00N/AN/AN/AINOVInovalon 0.00N/AN/AN/ALPHMLee Pharmaceuticals 0.00N/AN/AN/APBSVPharma-Bio Serv 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCHRCheer$147.20M0.09$2.83 per share0.41$29.66 per share0.04INOVInovalon$667.52M7.65$0.99 per share33.35$4.94 per share6.66LPHMLee PharmaceuticalsN/AN/AN/AN/AN/AN/APBSVPharma-Bio Serv$9.51M1.45N/AN/A$0.60 per share1.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCHRCheer$25.97MN/A0.00∞N/AN/AN/AN/AN/AINOVInovalon$22.58M$0.3496.7049.072.996.73%10.97%4.10%N/ALPHMLee PharmaceuticalsN/AN/A0.00N/AN/AN/AN/AN/AN/APBSVPharma-Bio Serv-$780K-$0.01N/A∞N/A-1.96%-1.47%-1.21%9/15/2025 (Estimated)Latest LPHM, CHR, PBSV, and INOV EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails9/15/2025N/APBSVPharma-Bio Serv$0.03N/AN/AN/A$3.00 millionN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCHRCheerN/AN/AN/AN/AN/AINOVInovalonN/AN/AN/AN/AN/ALPHMLee PharmaceuticalsN/AN/AN/AN/AN/APBSVPharma-Bio ServN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCHRCheerN/A8.297.66INOVInovalon1.172.402.40LPHMLee PharmaceuticalsN/AN/AN/APBSVPharma-Bio ServN/A7.547.54Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCHRCheer18.54%INOVInovalon33.15%LPHMLee PharmaceuticalsN/APBSVPharma-Bio ServN/AInsider OwnershipCompanyInsider OwnershipCHRCheer41.70%INOVInovalon49.75%LPHMLee Pharmaceuticals55.00%PBSVPharma-Bio Serv12.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCHRCheer12711.64 million6.78 millionN/AINOVInovalon1,836155.25 million78.01 millionNo DataLPHMLee Pharmaceuticals135.16 million15.82 millionNot OptionablePBSVPharma-Bio Serv18522.93 million20.04 millionNot OptionableLPHM, CHR, PBSV, and INOV HeadlinesRecent News About These CompaniesPBSV Pharma-Bio Serv, Inc. - Seeking AlphaJune 26, 2025 | seekingalpha.comOTC:PBSV Financials | Pharma-Bio Serv Inc - Investing.comJune 26, 2025 | investing.comPBSV Decisions Paying OffJune 19, 2025 | msn.comPharma-Bio Serv Announces Results for the Quarter Ended April 30, 2025June 16, 2025 | accessnewswire.comAPBSV Returns to GrowthMarch 18, 2025 | msn.comPharma-Bio Serv Announces Results for the Quarter Ended January 31, 2025March 17, 2025 | accessnewswire.comAPharma-Bio Serv Inc.: Pharma-Bio Serv Announces Full Year ResultsJanuary 31, 2025 | finanznachrichten.dePBSV Released Earnings and Declares DividendJanuary 30, 2025 | msn.comPharma-Bio Serv declares special dividend for shareholdersJanuary 30, 2025 | msn.comPharma-Bio Serv Announces Full Year ResultsJanuary 29, 2025 | accessnewswire.comAPharma-Bio Serv Announces Special DividendJanuary 29, 2025 | accessnewswire.comAScotiabank Initiates Coverage of BridgeBio Pharma (BBIO) with Sector Outperform RecommendationOctober 17, 2024 | msn.comBPGbio to Present on E2-based Approach to Targeted Protein Degradation at US Pharma Partnering SummitOctober 15, 2024 | standard-journal.comSBristol Myers, 2seventy bio halt enrollment in Abecma late-stage trialSeptember 25, 2024 | msn.comPBSV Makes Progress on ImprovementsSeptember 17, 2024 | msn.comPharma-Bio Serv Announces Results for the Quarter Ended July 31, 2024September 16, 2024 | accesswire.comASolving pharma’s patient services paradoxAugust 31, 2024 | pharmaphorum.comPVersant’s Jerel Davis on build-to-buy deals and pharma investmentAugust 28, 2024 | biopharmadive.comBPharma-Bio Serv Inc PBSVAugust 8, 2024 | morningstar.comMSamsung Biologics joins the Pharmaceutical Supply Chain Initiative as Supplier PartnerAugust 6, 2024 | msn.comMedia Sentiment Over TimeLPHM, CHR, PBSV, and INOV Company DescriptionsCheer NASDAQ:CHR$1.16 +0.02 (+1.75%) Closing price 08/29/2025 03:44 PM EasternExtended Trading$1.19 +0.03 (+2.59%) As of 04:17 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cheer Holding, Inc., through its subsidiaries, provides advertisement and content production services in the People's Republic of China. It operates through Cheers APP Internet Business and Traditional Media Businesses segments. The company also engages in mobile and online advertising, and media and entertainment businesses. In addition, it operates CHEERS app, an integrated e-commerce service with professionally produced content; CHEERS Video app, a media platform that engages users with content; and CHEERS e-Mall, an e-Mall app that offers products to the users through third party merchants through live streaming, online short videos, and online games. The company also provides CHEERS Telepathy, an artificial intelligence content creation platform; CHEERS Open Data, a platform that provides industry solutions; CheerCar, an interactive entertainment app; CheerReal, a digital collection NFT app; and production, such as short videos, online variety shows, online drama, live stream, and Cheers series. In addition, it is developing CheerChat App, a social app; and CHEERS Metaverse, a platform to provide immersive digital experiences. The company was formerly known as Glory Star New Media Group Holdings Limited and changed its name to Cheer Holding, Inc. in November 2023. Cheer Holding, Inc. was founded in 2016 and is headquartered in Beijing, the People's Republic of China.Inovalon NASDAQ:INOVInovalon Holdings, Inc. engages in the development of cloud-based platforms for the healthcare industry. Its products include datasets, integration technologies, predictive analytics, and related services. The company was founded in 1998 and is headquartered in Bowie, MD.Lee Pharmaceuticals OTCMKTS:LPHMLee Pharmaceuticals, Inc., through its subsidiary, RONN Motor Group, Inc., focuses on the design and development, manufacture, marketing, and sale of all-electric, hydrogen-fuel cell, and zero-emission new energy vehicles (NEVs) in the United States, China, and internationally. It intends to offer hydrogen fuel cell NEVs, including sports cars, sedans, SUVs, trucks, and buses. The company was founded in 2013 and is based in Scottsdale, Arizona.Pharma-Bio Serv OTCMKTS:PBSV$0.60 0.00 (0.00%) As of 08/29/2025 03:26 PM EasternPharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 08/25 - 08/29 Ollie’s Bargain Outlet: Buy it While It’s Still a Bargain Tencent Music Stock Outshines Spotify as China’s Music Giant With Shares Near Highs, Here's to Watch in Broadcom's Q3 Report Best Buy Marketplace: Potential Growth Catalyst or Risky Gimmick? DICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy? CrowdStrike at a Crossroads: AI Halo vs. Risks Snowflake’s Snowballing Business and Robust Stock Price Outlook Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
